Parkinson's disease-specific α-Synuclein variants potentially drive Lewy body formation by engaging in promiscuous and non-functional interactions

Commun Biol. 2026 Jan 8;9(1):165. doi: 10.1038/s42003-025-09395-9.

Abstract

Lewy bodies (LBs), a pathological hallmark of synucleinopathies, are heterogeneous inclusions that contain α-Synuclein (αSyn) alongside numerous proteins, lipids, and damaged organelles. Current αSyn-fibrillization centric aggregation/phase separation models fail to explain how diverse cellular components are sequestered by disease-specific αSyn variants during LB formation. In the crowded intracellular milieu, proteins constantly encounter one another, but functional protein-protein interactions must outweigh disease-causing 'hydrophobicity' driven non-functional interactions. Although αSyn wild-type (WT) has a hydrophobic (NAC) core, it is shielded by long-range intramolecular interactions, rendering it "inert." In contrast, Parkinson's disease (PD)-specific αSyn variants-S129 phosphorylation and C-terminal truncations-aggregate and phase separate more rapidly, suggesting hydrophobic exposure. We hypothesize that exposed hydrophobic core in PD-specific αSyn variants not only drives aggregation and phase separation but also promotes promiscuous, non-functional binding to diverse proteins. Using various biochemical and biophysical approaches, we demonstrate that αSynWT engages in functional interactions, whereas C-terminal acidic tail truncated αSyn1-103 and S129-phosphomimicking (S129E) mutant are "reactive," displaying broad, non-functional aberrant binding and impairing chaperone-mediated refolding. Based on our study, we propose a 'Multifactorial Random Disorder Model' outlining how PD-specific αSyn variants drive LB formation through non-functional heterotypic interactions.

MeSH terms

  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Lewy Bodies* / metabolism
  • Lewy Bodies* / pathology
  • Parkinson Disease* / genetics
  • Parkinson Disease* / metabolism
  • Parkinson Disease* / pathology
  • Phosphorylation
  • Protein Binding
  • alpha-Synuclein* / chemistry
  • alpha-Synuclein* / genetics
  • alpha-Synuclein* / metabolism

Substances

  • alpha-Synuclein
  • SNCA protein, human